Study of Treatment for HPV16+ ASC-US or LSIL

Abroad (travel likely)RecruitingPHASE1

Conditions

ASC-US · LSIL

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UAB | The University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Meg Thomas) · margaretannthomas@uabmc.edu
Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Kimberly Levinson, M.D.) · klevins1@jhmi.edu
Contact: Study coordinator (Richard Roden) · roden@jhmi.edu · 410=502-5161

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

High-risk HPV (Any Strain) · LSIL, Low Grade Squamous Intraepithelial Lesion · ASC-US

Abroad (travel likely)RecruitingPHASE2

Shatin, Hong Kong

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

I) Atypical Squamous Cells of Undetermined Significance (ASC-US) · II) Atypical Glandular Cells of Uncertain Significance (AGUS) · III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3

Abroad (travel likely)Recruiting

Mexico City, Mexico